Representatives of 12 companies and 80 investment institutions participated in a new financial service platform for bio-pharmaceutical companies at PKU Health Industrial Park.

Five bio-pharmaceutical companies presented their projects, covering areas such as genetic tests, medical devices, healthcare informatics, and implantation of heart valve prosthesis.

The PKU Health Industrial Park, run by PKU International HealthCare Group, established a pharmaceutical industry cluster integrating pharmaceutical R&D, production and circulation with laboratories qualified for FDA GLP/cGMP standards.

About 200 bio-pharmaceutical companies are expected to join the park over the next few years.

Edited by Wang Yifei and Niva Whyman